Immorta Bio Revenue

Biotechnology Research • Fisher Island, Florida, United States • 1-10 Employees

Immorta Bio revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at Immorta Bio

Thomas Ichim

President and Chief Scientific Officer

Company overview

Headquarters	7064 Fisher Island Dr, Miami Beach, Florida 33109, US
Website	immortabio.com
NAICS	541714
Founded	2023
Employees	1-10
Socials

Immorta Bio Email Formats

Immorta Bio uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@immortabio.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@immortabio.com	100%

About Immorta Bio

Immorta Bio, Inc, a regenerative medicine company dedicated to providing patient specific therapeutic solutions for Treating Diseases of Aging and Treating Aging as Disease™. We are developing personalized stem cell technologies that provide the greatest promise in the fight against diseases of aging.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Immorta Bio has 5 employees across 5 departments.

Departments

Number of employees

Funding Data

Immorta Bio has never raised funding before.

Immorta Bio Tech Stack

Discover the technologies and tools that power Immorta Bio's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

core-js

JavaScript libraries

Google Analytics

Analytics

jsDelivr

CDN

Microsoft 365

Frequently asked questions

Immorta Bio is located in Fisher Island, Florida, US.

Immorta Bio generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Immorta Bio has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Immorta Bio was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Immorta Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Immorta Bio

Thomas Ichim

President and Chief Scientific Officer

4.8

40,000 users